Published in AIDS Weekly, September 9th, 1996
Onconase is an anticancer ribonuclease which degraded viral RNA while not affecting normal cellular ribosomal RNA and messenger RNAs. "These results demonstrate that Onconase, at non-cytotoxic concentrations, can effectively and selectively inhibit replication of [HIV] in vitro by more than 90 percent without necessarily killing the HIV harboring cell," stated Dr. Richard Youle, U.S. National Institute of Neurological Disorders and Stroke...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.